home / stock / bicx / bicx news

BICX News and Press, BioCorRx Inc. From 12/07/22

Stock Information
Company Name: BioCorRx Inc.
Stock Symbol: BICX
Market: OTC
Website: biocorrx.com
Menu
BICX BICX Quote BICX Short BICX News BICX Articles BICX Message Board
Get BICX Alerts

News, Short Squeeze, Breakout and More Instantly...
BICX - BioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States

ANAHEIM, CA - ( NewMediaWire ) - December 07, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that it has partnered with Government Plus LLC, a leading provide...
BICX - BioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.

Anaheim, CA - ( NewMediaWire ) - November 22, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that its board of directors has authorized the exploration o...

BICX - BioCorRx Provides Business Update for the Third Quarter of 2022

ANAHEIM, CA - ( NewMediaWire ) - November 15, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the third quarter ended September 30, 2...

BICX - BioCorRx reports results

BioCorRx press release ( OTCQB:BICX ): The Co. saw an increase in revenue in the third quarter of 2022 due to the increased number of patients treated at licensed clinics. Furthermore, they were pleased to see that membership/program fees also increased for the third quarter o...
BICX - BioCorRx to Present at the LD Micro Main Event XV on October 25th

Anaheim, California--(Newsfile Corp. - October 24, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, a...

BICX - BioCorRx to Participate at the LD Micro Main Event XV

Anaheim, California--(Newsfile Corp. - October 20, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, a...

BICX - BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the last subject has been en...
BICX - BioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference

ANAHEIM, CA - ( NewMediaWire ) - September 06, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, CEO, CFO, and Director of BioCorRx, wi...

BICX - BioCorRx GAAP EPS of -$0.19, revenue of $16.01M

BioCorRx press release ( OTCQB:BICX ): Q2 GAAP EPS of -$0.19. Revenue of $16.01M (+1.8% Y/Y). For further details see: BioCorRx GAAP EPS of -$0.19, revenue of $16.01M

BICX - BioCorRx Provides Business Update for the Second Quarter of 2022

ANAHEIM, CA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the second qu...
Previous 10 Next 10